P13637 (AT1A3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 136.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sodium/potassium-transporting ATPase subunit alpha-3 Short name=Na(+)/K(+) ATPase alpha-3 subunit EC=3.6.3.9 Alternative name(s): Na(+)/K(+) ATPase alpha(III) subunit Sodium pump subunit alpha-3 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 1013 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. |
| Catalytic activity | ATP + H2O + Na+(In) + K+(Out) = ADP + phosphate + Na+(Out) + K+(In). |
| Subunit structure | Composed of three subunits: alpha (catalytic), beta and gamma. |
| Subcellular location | |
| Involvement in disease | Defects in ATP1A3 are the cause of dystonia type 12 (DYT12) [MIM:128235]; also known as rapid-onset dystonia parkinsonism (RDP). DYT12 is an autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability. Ref.10 |
| Sequence similarities | Belongs to the cation transport ATPase (P-type) (TC 3.A.3) family. Type IIC subfamily. [View classification] |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1013 | 1013 | Sodium/potassium-transporting ATPase subunit alpha-3 | PRO_0000046298 | |||||
Regions | |||||||||
| Topological domain | 1 – 77 | 77 | Cytoplasmic Potential | ||||||
| Transmembrane | 78 – 98 | 21 | Helical; Potential | ||||||
| Topological domain | 99 – 121 | 23 | Extracellular Potential | ||||||
| Transmembrane | 122 – 142 | 21 | Helical; Potential | ||||||
| Topological domain | 143 – 278 | 136 | Cytoplasmic Potential | ||||||
| Transmembrane | 279 – 298 | 20 | Helical; Potential | ||||||
| Topological domain | 299 – 310 | 12 | Extracellular Potential | ||||||
| Transmembrane | 311 – 328 | 18 | Helical; Potential | ||||||
| Topological domain | 329 – 762 | 434 | Cytoplasmic Potential | ||||||
| Transmembrane | 763 – 782 | 20 | Helical; Potential | ||||||
| Topological domain | 783 – 792 | 10 | Extracellular Potential | ||||||
| Transmembrane | 793 – 813 | 21 | Helical; Potential | ||||||
| Topological domain | 814 – 833 | 20 | Cytoplasmic Potential | ||||||
| Transmembrane | 834 – 856 | 23 | Helical; Potential | ||||||
| Topological domain | 857 – 908 | 52 | Extracellular Potential | ||||||
| Transmembrane | 909 – 928 | 20 | Helical; Potential | ||||||
| Topological domain | 929 – 941 | 13 | Cytoplasmic Potential | ||||||
| Transmembrane | 942 – 960 | 19 | Helical; Potential | ||||||
| Topological domain | 961 – 975 | 15 | Extracellular Potential | ||||||
| Transmembrane | 976 – 996 | 21 | Helical; Potential | ||||||
| Topological domain | 997 – 1013 | 17 | Cytoplasmic Potential | ||||||
| Region | 72 – 74 | 3 | Interaction with phosphoinositide-3 kinase By similarity | ||||||
Sites | |||||||||
| Active site | 366 | 1 | 4-aspartylphosphate intermediate By similarity | ||||||
| Metal binding | 707 | 1 | Magnesium By similarity | ||||||
| Metal binding | 711 | 1 | Magnesium By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 265 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 368 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 493 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 548 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 549 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 933 | 1 | Phosphoserine; by PKA By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 274 | 1 | I → T in DYT12. Ref.10 | VAR_026735 | |||||
| Natural variant | 277 | 1 | E → K in DYT12. Ref.10 | VAR_026736 | |||||
| Natural variant | 613 | 1 | T → M in DYT12. Ref.10 | VAR_026737 | |||||
| Natural variant | 758 | 1 | I → S in DYT12. Ref.10 | VAR_026738 | |||||
| Natural variant | 780 | 1 | F → L in DYT12. Ref.10 | VAR_026739 | |||||
| Natural variant | 801 | 1 | D → Y in DYT12. Ref.10 | VAR_026740 | |||||
Experimental info | |||||||||
| Sequence conflict | 1 – 2 | 2 | MG → MEIH in CAA31390. Ref.2 | ||||||
| Sequence conflict | 336 | 1 | L → V in AAA51798. Ref.1 | ||||||
| Sequence conflict | 336 | 1 | L → V in CAA31390. Ref.2 | ||||||
| Sequence conflict | 336 | 1 | L → V in AAA52285. Ref.5 | ||||||
| Sequence conflict | 336 | 1 | L → V in AAA58380. Ref.7 | ||||||
| Sequence conflict | 380 | 1 | H → T in AAA52285. Ref.5 | ||||||
| Sequence conflict | 421 | 1 | A → P in AAA58380. Ref.7 | ||||||
| Sequence conflict | 430 | 1 | I → M in CAA31390. Ref.2 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ in AAA51798. Ref.1 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ in CAA31390. Ref.2 | ||||||
| Sequence conflict | 555 – 557 | 3 | FPK → YPQ in AAA52286. Ref.5 | ||||||
| Sequence conflict | 577 | 1 | G → P in AAA51798. Ref.1 | ||||||
| Sequence conflict | 583 | 1 | D → G in AAA51798. Ref.1 | ||||||
| Sequence conflict | 583 | 1 | D → G in CAA31390. Ref.2 | ||||||
| Sequence conflict | 583 | 1 | D → G in AAA52286. Ref.5 | ||||||
| Sequence conflict | 919 | 1 | V → A in AAA52286. Ref.5 | ||||||
| Sequence conflict | 944 | 1 | L → M in AAA52286. Ref.5 | ||||||
| Sequence conflict | 982 | 1 | F → S in CAA31390. Ref.2 | ||||||
| Sequence conflict | 1006 | 1 | W → S in AAA51798. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M37457 M37456 Genomic DNA. Translation: AAA51798.1.X12910 X12923 Genomic DNA. Translation: CAA31390.1.AC010616 Genomic DNA. No translation available. BC009282 mRNA. Translation: AAH09282.1. BC009394 mRNA. Translation: AAH09394.1. BC015566 mRNA. Translation: AAH15566.1. M28286, M28284, M28285 Genomic DNA. Translation: AAA52285.1. M28293 M28292 Genomic DNA. Translation: AAA52286.1.M27577, M27570, M27573 Genomic DNA. Translation: AAA58380.1. |
| IPI | IPI00302840. |
| PIR | S00801. |
| RefSeq | NP_689509.1. NM_152296.3. |
| UniGene | Hs.515427. |
3D structure databases | |
| ProteinModelPortal | P13637. |
| SMR | P13637. Positions 16-1013. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P13637. 2 interactions. |
| MINT | MINT-2857038. |
| STRING | P13637. |
Protein family/group databases | |
| TCDB | 3.A.3.1.1. P-type ATPase (P-ATPase) superfamily. |
PTM databases | |
| PhosphoSite | P13637. |
Polymorphism databases | |
| DMDM | 116241260. |
Proteomic databases | |
| PRIDE | P13637. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000302102; ENSP00000302397; ENSG00000105409. |
| GeneID | 478. |
| KEGG | hsa:478. |
| UCSC | uc002osg.1. human. |
Organism-specific databases | |
| CTD | 478. |
| GeneCards | GC19M042470. |
| H-InvDB | HIX0015165. |
| HGNC | HGNC:801. ATP1A3. |
| HPA | CAB001988. |
| MIM | 128235. phenotype. 182350. gene. |
| neXtProt | NX_P13637. |
| Orphanet | 71517. Rapid-onset dystonia-parkinsonism. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG17690. |
| HOVERGEN | HBG004298. |
| InParanoid | P13637. |
| OrthoDB | EOG46MBHS. |
| PhylomeDB | P13637. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P13637. |
| Bgee | P13637. |
| CleanEx | HS_ATP1A3. |
| Genevestigator | P13637. |
| GermOnline | ENSG00000105409. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR023306. ATPase_cation_domN. IPR008250. ATPase_P-typ_ATPase-assoc-dom. IPR005775. ATPase_P-typ_cation-ex_asu_euk. IPR006069. ATPase_P-typ_cation-exchng_asu. IPR006068. ATPase_P-typ_cation-transptr_C. IPR004014. ATPase_P-typ_cation-transptr_N. IPR023300. ATPase_P-typ_cyto_domA. IPR023299. ATPase_P-typ_cyto_domN. IPR001757. ATPase_P-typ_ion-transptr. IPR018303. ATPase_P-typ_P_site. IPR023298. ATPase_P-typ_TM_dom. IPR005834. Dehalogen-like_hydro. IPR023214. HAD-like_dom. [Graphical view] |
| Gene3D | G3DSA:2.70.150.10. ATPase_P-typ_cyto_domA. 1 hit. G3DSA:3.40.1110.10. ATPase_P-typ_cyto_domN. 1 hit. G3DSA:1.20.1110.10. ATPase_P-typ_TM_dom. 2 hits. |
| KO | K01539. |
| Pfam | PF00689. Cation_ATPase_C. 1 hit. PF00690. Cation_ATPase_N. 1 hit. PF00122. E1-E2_ATPase. 1 hit. PF00702. Hydrolase. 1 hit. [Graphical view] |
| PRINTS | PR00119. CATATPASE. PR00121. NAKATPASE. |
| SMART | SM00831. Cation_ATPase_N. 1 hit. [Graphical view] |
| SUPFAM | SSF81660. ATPase_cation_domN. 1 hit. SSF56784. HAD-like_dom. 1 hit. |
| TIGRFAMs | TIGR01106. ATPase-IIC_X-K. 1 hit. TIGR01494. ATPase_P-type. 2 hits. |
| PROSITE | PS00154. ATPASE_E1_E2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 1981. |
| SOURCE | Search... |
Entry information
| Entry name | AT1A3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P13637 Secondary accession number(s): Q16732, Q16735, Q969K5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with